References
- Gomez R, Romero R, Nien JK et al. Antibiotic administration to patients with preterm premature rupture of membranes does not eradicate intra-amniotic infection. J. Matern. Fetal Neonatal Med.20, 167–173 (2007).
- Kenyon S, Boulvain M, Neilson J. Antibiotics for preterm rupture of the membranes: a systematic review. Obstet. Gynecol.104, 1051–1057 (2004).
- Bryant-Greenwood GD, Millar LK. Human fetal membranes: their preterm premature rupture. Biol. Reprod.63, 1575–1579 (2000).
- Cooperstock MS, Tummaru R, Bakewell J, Schramm W. Twin birth weight discordance and risk of preterm birth. Am. J. Obstet. Gynecol.183, 63–67 (2000).
- Fortunato SJ, Menon R, Bryant C, Lombardi SJ. Programmed cell death (apoptosis) as a possible pathway to metalloproteinase activation and fetal membrane degradation in premature rupture of membranes. Am. J. Obstet. Gynecol.182, 1468–1476 (2000).
- Sagol S, Sagol O, Ozkal S, Asena U. Role of apoptosis, bcl-2 and bax protein expression in premature rupture of fetal membranes. J. Reprod. Med.47, 809–815 (2002).
- Fortunato SJ, Menon R, Lombardi SJ. MMP/TIMP imbalance in amniotic fluid during PROM: an indirect support for endogenous pathway to membrane rupture. J. Perinat. Med.27, 362–368 (1999).
- Barrett BM, Sowell A, Gunter E, Wang M. Potential role of ascorbic acid and b-carotene in the prevention of preterm rupture of fetal membranes. Int. J. Vitam. Nutr. Res.64, 192–197 (1994).
- Barrett B, Gunter E, Jenkins J, Wang M. Ascorbic acid concentration in amniotic fluid in late pregnancy. Biol. Neonate60, 333–335 (1991).
- Witt A, Sommer E, Cichna M et al. Placental passage of clarithromycin surpasses other macrolide antibiotics. Am. J. Obstet. Gynecol.188, 816–819 (2003).
- Fidel P, Ghezzi F, Romero R et al. The effect of antibiotic therapy on intrauterine infection-induced preterm parturition in rabbits. J. Matern. Fetal Neonatal Med.14, 57–64 (2003).
- Ugwumadu A, Reid F, Hay P, Manyonda I, Jeffrey I. Oral clindamycin and histologic chorioamnionitis in women with abnormal vaginal flora. Obstet. Gynecol.107, 863–868 (2006).
- Goldenberg RL, Mudenda V, Read JS et al. HPTN 024 study: histologic chorioamnionitis, antibiotics and adverse infant outcomes in a predominantly HIV-1-infected African population. Am. J. Obstet. Gynecol.195, 1065–1074 (2006).
- Hannah M. Antibiotics for preterm prelabour rupture of membranes and preterm labour? Lancet357, 973–974 (2001).
- Kenyon S, Taylor DJ. The effect of the publication of a major clinical trial in a high impact journal on clinical practice: the ORACLE trial experience. Br. J. Obstet. Gynaecol.109, 1341–1343 (2002).
- Murch SH. Toll of allergy reduced by probiotics. Lancet375, 1057–1059 (2001).
- Manning SD, Foxman B, Pierson CL, Tallman P, Baker CJ, Pearlman MD. Correlates of antibiotic-resistant group B Streptococcus isolated from pregnant women. Obstet. Gynecol.101, 74–79 (2003).
- Manning SD, Pearlman MD, Tallman P, Pierson CL, Foxman B. Frequency of antibiotic resistance among group B Streptococcus isolated from healthy college students. Clin. Infect. Dis.33, E137–E139 (2001).
- Pearlman MD, Pierson CL, Faix RG. Frequent resistance of clinical group B streptococci isolates to clindamycin and erythromycin. Obstet. Gynecol.92, 258–261 (1998).